News / Taiwan / economic_daily
Ho-Rong Tech Invests NT$1.55 Billion in Miaoli for New BNCT R&D and Manufacturing Hub
Health Technology · Biotechnology · economic_daily · 2026-10-15
7799
Boron Neutron Capture Therapy (BNCT) specialist Ho-Rong Tech has acquired a 2.19-hectare site in Miaoli for NT$1.55 billion to build a high-end medical accelerator and drug development facility.
What Happened
Strategic Land Acquisition: Ho-Rong Tech announced the acquisition of a 2.19-hectare industrial site in the Miaoli High Speed Rail special zone for NT$1.55 billion. This investment is intended to establish a state-of-the-art facility dedicated to the research, development, and manufacturing of high-end medical accelerators and specialized drugs.
Expanding Production Capacity: The company plans to leverage this new base to scale up its BNCT equipment manufacturing and R&D capabilities to meet growing international demand. The facility will serve as a cross-disciplinary precision medicine platform, integrating system assembly, testing, and verification processes.
Drug Development and Supply Chain: Ho-Rong Tech intends to develop dedicated spaces for pharmaceutical research and manufacturing processes to advance its BNCT diagnostic and therapeutic offerings. By phasing in production lines based on market demand, the company aims to complement existing industry ecosystems and ensure long-term supply chain stability.
Building a Precision Medicine Ecosystem: The project aims to complete Ho-Rong Tech's comprehensive BNCT solution by linking accelerator technology with nuclear medicine. Capitalizing on the strategic location near the Hsinchu-Miaoli-Taichung technology corridor, the company seeks to foster a robust ecosystem for advanced cancer treatment.